- Home
- HPS vs EBS Comparison
HPS vs EBS Comparison
Compare HPS & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HPS
- EBS
- Stock Information
- Founded
- HPS 2003
- EBS 1998
- Country
- HPS United States
- EBS United States
- Employees
- HPS N/A
- EBS 900
- Industry
- HPS Investment Managers
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- HPS Finance
- EBS Health Care
- Exchange
- HPS Nasdaq
- EBS Nasdaq
- Market Cap
- HPS 451.0M
- EBS 353.9M
- IPO Year
- HPS N/A
- EBS 2006
- Fundamental
- Price
- HPS $14.30
- EBS $6.61
- Analyst Decision
- HPS
- EBS Strong Buy
- Analyst Count
- HPS 0
- EBS 3
- Target Price
- HPS N/A
- EBS $14.33
- AVG Volume (30 Days)
- HPS 58.4K
- EBS 1.3M
- Earning Date
- HPS 01-01-0001
- EBS 08-05-2025
- Dividend Yield
- HPS 8.62%
- EBS N/A
- EPS Growth
- HPS N/A
- EBS N/A
- EPS
- HPS N/A
- EBS N/A
- Revenue
- HPS N/A
- EBS $965,400,000.00
- Revenue This Year
- HPS N/A
- EBS N/A
- Revenue Next Year
- HPS N/A
- EBS $18.88
- P/E Ratio
- HPS N/A
- EBS N/A
- Revenue Growth
- HPS N/A
- EBS N/A
- 52 Week Low
- HPS $11.79
- EBS $4.02
- 52 Week High
- HPS $15.40
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- HPS 49.30
- EBS 47.87
- Support Level
- HPS $14.03
- EBS $6.22
- Resistance Level
- HPS $14.20
- EBS $6.95
- Average True Range (ATR)
- HPS 0.12
- EBS 0.32
- MACD
- HPS 0.02
- EBS -0.05
- Stochastic Oscillator
- HPS 45.76
- EBS 21.81
About HPS John Hancock Preferred Income Fund III Preferred Income Fund III
John Hancock Preferred Income Fund III is a closed-end, diversified management investment company. Its investment objective is to provide a high level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. It seeks to achieve the objectives by investing a majority of its assets in preferred stocks and other preferred securities, including convertible preferred securities. The portfolio composition of the company consists of the U.S. preferred securities, foreign preferred securities, common stocks, corporate bonds, and the short-term investments.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.